ArteraAI Breast Gains FDA Clearance for Cancer Risk
SAN FRANCISCO, May 6, 2026 Artera announced that the U.S. Food and Drug Administration (FDA) has granted clearance for...
RNA therapeutics
Advertisement
GSK Signs $1B SiranBio siRNA Cardiometabolic Deal
SUZHOU, China, May 6, 2026 SiranBio announced a major global licensing agreement with GSK for its investigational siRNA therapeutic...
Sail Biomedicines Advances In Vivo eRNA CAR-T Data
CAMBRIDGE, Mass., April 27, 2026 Sail Biomedicines announced it will present new preclinical data supporting its In Vivo eRNA™...
Atrium Therapeutics Earns $15M Milestone from Bristol Myers Squibb
San Diego, California, USA – April 23, 2026 Atrium Therapeutics announced it has achieved a $15 million development milestone...
Interna, Daiichi Sankyo Partner on Drug Delivery Tech
PETACH TIKVA, Israel, April 16, 2026 Interna Therapeutics has announced a strategic research collaboration with Daiichi Sankyo to advance...
Advertisements
Vivatides Therapeutics Raises $54M to Expand RNA Therapies
Boston, Massachusetts | April 13, 2026 Vivatides Therapeutics has announced the successful completion of a $54 million oversubscribed Series...
Alloy and Biogen Partner on Antisense Drug Platform
BOSTON, Massachusetts, United States, April 7, 2026 Alloy Therapeutics Inc. announced a multi-target collaboration and license agreement with Biogen...
Alltrna Launches First Human Trial for tRNA Therapy AP003
CAMBRIDGE, Mass., USA, March 31, 2026 Alltrna has received regulatory approval to initiate the first-in-human clinical trial of AP003,...
PureTech, Seaport Advance GlyphAllo in Depression Therapy
BOSTON, Massachusetts, March 26, 2026 PureTech Health has announced that its founded entity, Seaport Therapeutics, has published first-in-human clinical...
Ionis Zilganersen NDA Gets FDA Priority Review
CARLSBAD, California, March 23, 2026 Ionis Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has accepted...
Advertisement
